Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    badie
Show Display Options
Rank Status Study
1 Recruiting Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
Conditions: Malignant Glioma;   Refractory Brain Neoplasm;   Recurrent Brain Neoplasm;   Glioblastoma
Interventions: Biological: IL13Rα2-specific, hinge-optimized, 41BB-costimulatory CAR/truncated CD19-expressing Autologous T lymphocytes;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Procedure: Magnetic Resonance Imaging;   Procedure: Magnetic Resonance Spectroscopic Imaging
2 Completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
Conditions: Anaplastic Astrocytoma;   Anaplastic Ependymoma;   Anaplastic Meningioma;   Anaplastic Oligodendroglioma;   Brain Stem Glioma;   Ependymoblastoma;   Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma;   Grade III Meningioma;   Meningeal Hemangiopericytoma;   Mixed Glioma;   Pineal Gland Astrocytoma;   Brain Tumor
Interventions: Biological: therapeutic allogeneic lymphocytes;   Biological: aldesleukin;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography
3 Terminated Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
Conditions: Pain;   Analgesia;   Hernia, Inguinal
Interventions: Drug: Gabapentin;   Other: placebo
4 Not yet recruiting The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy
Condition: Heart Failure
Intervention: Device: CRT+NAVH
5 Recruiting Letrozole in Assisted Reproductive Technology
Condition: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .
Interventions: Drug: Letrezole plus FSH;   Drug: Standard protocol for induction of ovulation

Study has passed its completion date and status has not been verified in more than two years.